Author:
Locatelli Chiara,Onnivello Sara,Gori Caterina,Ramacieri Giuseppe,Pulina Francesca,Marcolin Chiara,Vianello Renzo,Vione Beatrice,Caracausi Maria,Pelleri Maria Chiara,Vitale Lorenza,Pirazzoli Gian Luca,Cocchi Guido,Corvaglia Luigi,Strippoli Pierluigi,Antonaros Francesca,Piovesan Allison,Lanfranchi Silvia
Abstract
AbstractDown syndrome (DS) is characterised by several clinical features including intellectual disability (ID) and craniofacial dysmorphisms. In 1976, Jackson and coll. identified a checklist of signs for clinical diagnosis of DS; the utility of these checklists in improving the accuracy of clinical diagnosis has been recently reaffirmed, but they have rarely been revised. The purpose of this work is to reassess the characteristic phenotypic signs and their frequencies in 233 DS subjects, following Jackson's checklist. 63.77% of the subjects showed more than 12 signs while none showed less than 5, confirming the effectiveness of Jackson's checklist for the clinical diagnosis of DS. An association between three phenotypic signs emerged, allowing us to distinguish two sub-phenotypes: Brachycephaly, short and broad Hands, short Neck (BHN), which is more frequent, and "non-BHN". The strong association of these signs might be interpreted in the context of the growth defects observed in DS children suggesting decreased cell proliferation. Lastly, cognitive assessments were investigated for 114 subjects. The lack of association between the presence of a physical sign or the number of signs present in a subject and cognitive skills disproves the stereotype that physical characteristics are predictive of degree of ID.
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Lejeune, J., Gauthier, M. & Turpin, R. Human chromosomes in tissue cultures. Comptes rendus hebdomadaires des seances de l’Academie des sciences 248, 602–603 (1959).
2. Pelleri, M. C. et al. Partial trisomy 21 map: Ten cases further supporting the highly restricted Down syndrome critical region (HR-DSCR) on human chromosome 21. Mol. Genet. Genomic Med. 7, e797 (2019).
3. Bull, M. J. Down syndrome. N. Engl. J. Med. 382, 2344–2352 (2020).
4. Anneren, G., Gustavson, K. H., Sara, V. R. & Tuvemo, T. Growth retardation in Down syndrome in relation to insulin-like growth factors and growth hormone. Am. J. Med. Genet. Suppl. 7, 59–62 (1990).
5. Gardiner, K. et al. Down syndrome: From understanding the neurobiology to therapy. J. Neurosci. 30, 14943–14945 (2010).